Shane Kannarr

Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration With Visual Field in Acquired Ptosis

Charles B. Slonim, Shane Foster, Mark Jaros et al. · JAMA Ophthalmology · 2020 · 35 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +12

Efficacy and Safety of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, for the Treatment of Keratoconjunctivitis Sicca: Pooled Analysis of a Phase 2b/3 and Phase 3 Study

John D. Sheppard, Shane Kannarr, Jodi Luchs et al. · Eye & Contact Lens Science & Clinical Practice · 2019 · 27 citations

Medicine, Dermatology, Ophthalmology +12

Safety and Efficacy of Twice-Daily Pilocarpine HCl in Presbyopia: The Virgo Phase 3, Randomized, Double-Masked, Controlled Study

Shane Kannarr, Shérif M. El-Harazi, Majid Moshirfar et al. · American Journal of Ophthalmology · 2023 · 24 citations · Full text

Medicine, Ophthalmology, Pharmacology +17

Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results

Jason Bacharach, David Wirta, Robert Smyth-Medina et al. · Clinical ophthalmology · 2021 · 19 citations · Full text

Medicine, Ophthalmology, Pharmacology +9

Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials

Robert Smyth-Medina, Josh Johnston, Douglas K. Devries et al. · Journal of Ocular Pharmacology and Therapeutics · 2019 · 18 citations

Medicine, Dermatology, Ophthalmology +13